apollo
logo
0
  1. Home
  2. Medicine
  3. Adricin 10 Injection 1's
  4. Health Queries for Adricin 10 Injection 1's
  5. I have gastroesophageal junction (GE junction) adenocarcinoma and received 3 cycles of ECF chemotherapy (Epirubicin, Cisplatin, and 5-FU). My WBC count has dropped from 9500 to 4300. What steps can be taken in the next cycle to prevent neutropenia or reduce bone marrow suppression? Will the drug doses need adjustment?

Have a query?

I have gastroesophageal junction (GE junction) adenocarcinoma and received 3 cycles of ECF chemotherapy (Epirubicin, Cisplatin, and 5-FU). My WBC count has dropped from 9500 to 4300. What steps can be taken in the next cycle to prevent neutropenia or reduce bone marrow suppression? Will the drug doses need adjustment?

Asked by Male, 36 ยท 27 days ago

A drop in white blood cells after ECF chemotherapy (Epirubicin, Cisplatin, and Fluorouracil) is common because these medicines affect the bone marrow, and a count of 4300 is mildly low but still needs monitoring. For the next cycle, your oncologist may reduce doses slightly, delay treatment to allow recovery, or add supportive injections like growth factors (G-CSF) to boost white cells and lower the risk of infection, depending on your overall health and how low your counts go. You can help by maintaining good nutrition, staying well hydrated, practising strict hygiene (like frequent handwashing and avoiding crowds or sick contacts), and reporting fever, sore throat, or weakness immediately, as infections can become serious when counts are low. The exact plan, including any dose adjustment, is individualised, so your doctor will balance effective cancer treatment with safety to minimise side effects.
user icon

Ask Apollo

AI powered Health Chatbot

Other Related topics like...

  1. Implications of WBC Drop

    • A decrease from 9500 to 4300 signifies bone marrow suppression and should be monitored to avoid neutropenia.
  2. Potential Side Effects of ECF Drugs

    • Epirubicin, Cisplatin, and 5-FU can cause bone marrow suppression, increasing the risk of infections.
  3. Dose Adjustment Considerations

    • Dose adjustments or delays might be required depending on WBC counts and clinical symptoms.
  4. Preventive Measures for Next Cycle

    • Consider using G-CSF growth factors, dose modification, and maintaining supportive care to decrease neutropenia risk.
  5. Specialist Consultation

    • Consult a medical oncologist for chemotherapy side effect management and a hematologist for severe cytopenias.

Answered 19 days ago